Zomacton?

What is Zomacton, and what are its uses?

Zomacton is a recombinant growth hormone derived from human genes, used to treat Growth Hormone Deficiency (GHD) in adults. According to 1, it is also used to treat short stature in children.

How does Zomacton work?

Zomacton replaces the growth hormone that the body cannot produce on its own. By stimulating growth hormone production, it helps to promote growth and development in children and adults with GHD.

Is Zomacton approved by regulatory agencies?

Yes, Zomacton has been approved by the FDA in the United States and the European Medicines Agency (EMA) in the European Union.

What is the patent status of Zomacton?

The patent of Zomacton was held by Pfizer but has since expired. As of my knowledge cutoff, the patent expired in 2, but it may continue to be available as a generic or biosimilar medication.

Are there any contraindications or side effects associated with Zomacton?

Zomacton can cause a range of side effects, including carpal tunnel syndrome, fluid retention, and diabetes. More severe side effects like tumors, leukemia, and stroke have also been reported but are rare.

Are there alternative treatments for Growth Hormone Deficiency?

Yes, other growth hormone deficiency medications, such as Genotropin, Norditropin, and Humatrope, are available.

Sources:

[1] DrugPatentWatch.com. (n.d.). Zomacton. Retrieved from https://www.drugpatentwatch.com/drugs/zomacton/

[2] DrugPatentWatch.com. (n.d.). ZOMACTON. Retrieved from https://www.drugpatentwatch.com/trademarks/pfizer/ZOMACTON/